Minimum Investment
₹14,896
Price Range
₹372 to ₹392
Lot Size
38 shares
Issue Size
₹409 Cr
About the Company
Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing.
Bookbuilding IPO
IPO Objectives
- Capacity expansion and upgradation of manufacturing facilities Establishment of a new R&D Centre;
- Repayment / prepayment of certain outstanding borrowings Working capital requirements
- Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and General corporate purposes
Important Dates
| Bid/Offer Opens On | 24-03-2026 |
| Bid/Offer Closes On | 27-03-2026 |
| Finalisation of Basis of Allotment | — |
| Initiation of Refunds | — |
| Credit of Shares to Demat | — |
| IPO Listing Date | — |
Frequently asked questions
What is the Sai Parenteral's IPO lot size?
The lot size is 38 shares with a minimum investment of ₹14,896.
When does the Sai Parenteral's IPO open and close?
Bidding is scheduled from 24-03-2026 to 27-03-2026 (subject to exchange updates).
How can I apply for the Sai Parenteral's IPO?
You can apply via the IPO Focuss - Ambica Finstock LLP mobile app during the bidding window using UPI or ASBA as available for this issue.
Grey Market Premium (GMP)
—
Registrar
Bigshare Services Pvt.Ltd.
Lead Managers
- Arihant Capital Markets Ltd.
Company Promoters
- Anil Kumar Karusala
- Vijitha Gorrepati and Karusala Aruna are company promoters.\r\n
